Of course success is dependant on acceptance by the end user! Take reference on the number of development kits, and those that have progressed to OEM partnerships.
You should also reference the poster they recently released about the productivity gains - reading 100 samples at once is better than manually look at individual labels.
The $600k debt facility is in relation to R&D credits - eg debt racked up and then paid off when the R&D credits come in. This was specifically made reference to in the open briefing.
As for the other stuff, I'll let you read through the announcements and make your own opinion.
- Forums
- ASX - By Stock
- Ann: Open Briefing
Of course success is dependant on acceptance by the end user!...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.737M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online